The global HIV epidemic continues to grow in certain regions while contracting in others, necessitating a broadened research agenda, including clinical pharmacology of tuberculosis, hepatitis, malaria, and immune activation/inflammation, underscoring the need for a coordinated quality assurance approach. A comprehensive program has been developed and implemented by the University at Buffalo HIV Clinical Pharmacology Quality Assurance and Quality Control Program, funded by the National Institutes of Health. Clinical Pharmacology & Therapeutics (2013); 93 6, 479-482. doi:10.1038/clpt.2013.62
No takes yet. Share an insight, caveat, or question.
DiFrancesco et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: